AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PULSE BIOSCIENCES, INC. Director's Dealing 2023

Jun 13, 2023

32093_dirs_2023-06-13_5ab0b5f0-468b-47fb-8874-316c4fcd24c6.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-05-25

Reporting Person: Levinson Mitchell E. (Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-25	Common Stock	X	10935	$2.05	Acquired	230843	Direct
2023-05-25	Common Stock	X	814	$2.05	Acquired	4135	Indirect
2023-05-25	Common Stock	X	143	$2.05	Acquired	734	Indirect
2023-05-25	Common Stock	X	143	$2.05	Acquired	734	Indirect
2023-05-25	Common Stock	X	143	$2.05	Acquired	734	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-25	Warrant (right to buy)	$2.05	X	10935	Disposed	2027-06-09	Common Stock (10935)	Direct
2023-05-25	Warrant (right to buy)	$2.05	X	814	Disposed	2027-06-09	Common Stock (814)	Indirect
2023-05-25	Warrant (right to buy)	$2.05	X	143	Disposed	2027-06-09	Common Stock (143)	Indirect
2023-05-25	Warrant (right to buy)	$2.05	X	143	Disposed	2027-06-09	Common Stock (143)	Indirect
2023-05-25	Warrant (right to buy)	$2.05	X	143	Disposed	2027-06-09	Common Stock (143)	Indirect